MIT’s Vaccine Delivers a Boost to T Cell Cancer Treatment
MIT researchers have developed a strategy to boost the effectiveness of CAR T cell therapy in eradicating solid tumors. By using a vaccine to enhance the response of these engineered T cells and stimulate the immune system to target various tumor antigens, they successfully addressed the issue of antigen variation, a major obstacle in treating solid tumors.An <span class="glossaryLink" aria-describedby="tt" data-cmtooltip="<div class=glossaryItemTitle>MIT</div><div…